Thursday, 2 July 2020

Consideration of Covid-19 Prevention Measures For Those Working In GMP Pharmaceuticals And Healthcare Facilities


Aside from expelled droplets through coughing and sneezing, it is not yet established if the virus survives long-term in the air and hence whether it can be classified as ‘airborne.’   This article then considers the measures that employers within the pharmaceutical and healthcare need to have in place in order to maintain staff safety and welfare. Whilst continuing to ensure that Good Manufacturing (GMP) standards are met.


The article also considers the measures that employers within the pharmaceutical and healthcare need to have in place in order to maintain staff safety and welfare. Whilst continuing to ensure that Good Manufacturing (GMP) standards are met. While the focus is on the causative agent of COVID-19, the information presented will help for assessing future pathogen outbreaks where additional public health measures are required.

Sandle, T. (2019) Consideration of Covid-19 Prevention Measures For Those Working In GMP Pharmaceuticals And Healthcare Facilities, Journal of Validation Technology, 26 (2).

See: https://www.ivtnetwork.com/article/consideration-covid-19-prevention-measures-those-working-gmp-pharmaceuticals-and-healthcare-

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

No comments:

Post a comment

Pharmaceutical Microbiology Resources

Special offers